Prudential Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
+12,120
| New | +$216K | ﹤0.01% | 2185 |
|
|
2025
Q1 | – | Sell |
-7,170
| Closed | -$214K | – | 2353 |
|
|
2024
Q4 | $214K | Buy |
+7,170
| New | +$214K | ﹤0.01% | 2076 |
|
|
2022
Q1 | – | Sell |
-1,998
| Closed | -$214K | – | 2667 |
|
|
2021
Q4 | $214K | Sell |
1,998
-201
| -9% | -$21.5K | ﹤0.01% | 2526 |
|
|
2021
Q3 | $288K | Sell |
2,199
-49
| -2% | -$6.42K | ﹤0.01% | 2341 |
|
|
2021
Q2 | $498K | Sell |
2,248
-30
| -1% | -$6.65K | ﹤0.01% | 2140 |
|
|
2021
Q1 | $301K | Hold |
2,278
| – | – | ﹤0.01% | 2271 |
|
|
2020
Q4 | $395K | Sell |
2,278
-34
| -1% | -$5.9K | ﹤0.01% | 2158 |
|
|
2020
Q3 | $257K | Buy |
+2,312
| New | +$257K | ﹤0.01% | 2218 |
|
|
2020
Q2 | – | Sell |
-38,537
| Closed | -$2.6M | – | 2448 |
|
|
2020
Q1 | $2.6M | Buy |
38,537
+30,326
| +369% | +$2.04M | 0.01% | 1240 |
|
|
2019
Q4 | $692K | Sell |
8,211
-309
| -4% | -$26K | ﹤0.01% | 1974 |
|
|
2019
Q3 | $637K | Sell |
8,520
-66,743
| -89% | -$4.99M | ﹤0.01% | 1984 |
|
|
2019
Q2 | $4.76M | Buy |
75,263
+67,873
| +918% | +$4.29M | 0.01% | 1182 |
|
|
2019
Q1 | $356K | Buy |
+7,390
| New | +$356K | ﹤0.01% | 2175 |
|
|
2018
Q4 | – | Sell |
-7,430
| Closed | -$389K | – | 2427 |
|
|
2018
Q3 | $389K | Buy |
7,430
+840
| +13% | +$44K | ﹤0.01% | 2114 |
|
|
2018
Q2 | $206K | Buy |
+6,590
| New | +$206K | ﹤0.01% | 2338 |
|